Volume | 1,158,741 |
|
|||||
News | - | ||||||
Day High | 1.16 | Low High |
|||||
Day Low | 1.08 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vaxart Inc | VXRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.11 | 1.08 | 1.16 | 1.16 | 1.08 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,268 | 1,158,741 | $ 1.13 | $ 1,305,916 | - | 0.53 - 1.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:34 | 25 | $ 1.1698 | USD |
Vaxart Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
174.84M | 152.04M | - | 107k | -107.76M | -0.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vaxart News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.19 | 1.25 | 1.03 | 1.12 | 1,320,975 | -0.04 | -3.36% |
1 Month | 1.17 | 1.54 | 1.03 | 1.25 | 1,860,434 | -0.02 | -1.71% |
3 Months | 0.595 | 1.54 | 0.53 | 1.02 | 2,019,849 | 0.555 | 93.28% |
6 Months | 0.74 | 1.54 | 0.53 | 0.9312864 | 1,270,343 | 0.41 | 55.41% |
1 Year | 0.7525 | 1.59 | 0.53 | 0.9190991 | 1,493,254 | 0.3975 | 52.82% |
3 Years | 6.85 | 11.108 | 0.53 | 6.01 | 4,229,525 | -5.70 | -83.21% |
5 Years | 1.61 | 24.90 | 0.2543 | 6.89 | 6,579,525 | -0.46 | -28.57% |
Vaxart Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |